---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011770"
form_type: "8-K"
ticker: "DMRA"
cik: "0001800315"
company_name: "Damora Therapeutics, Inc."
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T00:57:41.482770+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Galecto stockholders elect two Class II directors and ratify auditor at 2022 annual meeting

## Summary
- Carl Goldfischer, M.D. elected with 11,025,408 votes for; David Shapiro, M.D. with 11,050,440 votes for.
- Ratification of EY Godkendt Revisionspartnerselskab as independent auditor for FY2022: 15,589,293 for, 33,022 against.
- 15,647,815 shares represented at meeting out of 25,261,832 entitled to vote; 3,360,631 broker non-votes on director election.

## SEC filing metadata
- accession: 0000950170-22-011770
- form_type: 8-K
- ticker: DMRA
- cik: 0001800315
- company_name: Damora Therapeutics, Inc.
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800315/000095017022011770/0000950170-22-011770-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800315/000095017022011770/glto-20220614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011770
- JSON: https://secwatch.observer/filing/0000950170-22-011770.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011770.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.